Nachega, Jean B.
Adetokunboh, Olatunji
Uthman, Olalekan A.
Knowlton, Amy W.
Altice, Frederick L.
Schechter, Mauro
Galárraga, Omar
Geng, Elvin
Peltzer, Karl
Chang, Larry W.
Van Cutsem, Gilles
Jaffar, Shabbar S.
Ford, Nathan
Mellins, Claude A.
Remien, Robert H.
Mills, Edward J.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (2UM1AI069521-08)
U.S. President’s Emergency Plan for AIDS Relief (T84HA21652-01-00)
Universiteit Stellenbosch (1 U2GGH001536-01)
National Institutes on Drug Abuse for Research (R01-DA 10186)
Wellcome Trust Southern Africa Consortium for Research Excellence (WT087537MA)
FAS Marie Curie International PostDoc (2012-0064)
Article History
First Online: 30 July 2016
Compliance with Ethical Standards
:
: Jean B. Nachega receives research grant support from the National Institutes of Health/National Institutes for Allergy and Infectious Disease, the AIDS Clinical Trial Group (ACTG)/Stellenbosch University Clinical Trial Unit (2UM1AI069521-08); the US President Emergency Plan for AIDS Relief (PEPFAR; T84HA21652-01-00) for Medical Education Partnership Initiative; the Stellenbosch University Collaborative Capacity Enhancement through Engagement with Districts (SUCCEED; 1 U2GGH001536-01); and the Wellcome Trust Southern Africa Consortium for Research Excellence (WT087537MA).Olalekan A. Uthman acknowledges support from the FAS Marie Curie International PostDoc (2012-0064).Frederick L. Altice is funded by the National Institutes on Drug Abuse for Research (R01-DA 10186; R01-DA 13805; R01-DA 017072).Olatunji Adetokunboh, Amy W. Knowlton, Mauro Schechter, Omar Galárraga, Elvin Geng, Karl Peltzer, Larry W. Chang, Gilles Van Cutsem, Shabbar S. Jaffar, Nathan Ford, Claude A. Mellins, Robert H. Remien, and Edward J. Mills declare that they have no conflict of interest
: This article does not contain any studies with human or animal subjects performed by any of the authors.